Skip to main content

Quarterly update

It was refreshing to approach my quarterly oncology appointment with no anxiety about my CT scan results. On Monday, my pulmonologist confirmed that my pulmonary function test results showed huge improvement. He said it's rare to see someone improve so much. For once, I'm an outlier in a good way! 

At my oncology appointment in Pittsburgh, Dr. Villaruz said my CT scan looked great. This is a relative term because there's still a lot going on with my lungs...but it was very reassuring to hear her say this. She thinks there's been some improvement since May and about the same compared to August. Functionally, I'm doing much better. I only use my portable while biking or lifting, and I'm going to start using my pulse oximeter to see if I even need it in those instances. (Although, exercise is on hiatus because I pulled a muscle last week and can't do anything that activates my glute. Aaaargh.)

People on Tagrisso develop resistance at a median of 18 months, meaning the drug stops working because the cancer has mutated. December 30 will mark 18 months for me (including the ~2 months I didn't take Tag while in and out of the hospital last year). Some people have taken Tag for 5 years or more without developing resistance. I'm doing very well now, but I often find myself scanning the horizon, wondering when storm clouds will appear. Dr. Villaruz reassured us that new drug treatments are constantly emerging, that there are lots of other options. Nonetheless, it is hard not to jump ahead and spin out scenarios. I want to appreciate where I am now and how far I've come rather than worry about where I might be down the road. 

I am reminded of a verse that Leland and I included in our wedding ceremony bulletin: “Go, eat your food with gladness, and drink your wine with a joyful heart, for it is now that God favors what you do” (Ecclesiastes 9:7). On that note, I will wrap up and head out to a holiday party.  

Comments

  1. Amen let us give thanks to the Lord who has brought you so far. He has never left you nor forsaken you. He has gone before you. I thank God for where you are now. God is gracious. Much love to you.

    ReplyDelete
  2. This is music in my ears! I'm so so happy for you. And proud of you, too. Lois C

    ReplyDelete
  3. Appreciate these updates and the good news - thanks for sharing! (Andy)

    ReplyDelete
  4. I agree that it is heartening to hear that you are doing well, Esther - Bill R.

    ReplyDelete
    Replies
    1. So glad to hear the continued good news. Celebrate the positive and focus on the now. And best wishes on the pulled glute. Much love, -Kristen

      Delete
  5. Dear Esther--Joining with you in thanking God!! So encouraging. He is faithful.

    ReplyDelete
  6. Glad to hear the good news. You are a powerhouse! Annyce

    ReplyDelete

Post a Comment

Popular posts from this blog

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...

38.6 months

September 18 marked 38.6 months (3 years, 2 months, 18 days) since I first started taking Tagrisso. Why is 38.6 months significant? Because it is the median overall survival in the FLAURA study, a landmark study (2014-16) comparing Tagrisso and older targeted therapies among patients with advanced non-small cell lung cancer, EGFR mutation, and no prior treatment. 279 patients received Tagrisso and 277 people received an older drug (in addition, all patients received at least one dose of a trial drug). Nearly 58% of patients had died when data collection stopped. However, patients in the Tagrisso group lived nearly 7 months longer (median) than the control group. When Leland and I initially read that number – 38.6 months – in the Tagrisso promotional materials, we were stunned. This was supposed to be good news? The median age in the FLAURA study was 64 and at the time (August 2022), I had just turned 50. But still, it was a sobering statistic. For the longest time, I didn't feel ...

A failure of institutional care

I just hit "send" on this letter to my dean and associate dean. Mic drop. I've never sent such a scathing letter, but it's definitely called for in this situation. I'm not expecting anything other than a "Oh, that wasn't how we intended to make you feel; our hands were tied" email. Dear Dean Lawless and Associate Dean Lloyd, When I wrote to Professor Land [my department head] to see if I could get a course release this fall due to having lung cancer plus complications from pulmonary embolism and COVID, I had no idea what I was in for. When faculty friends in other colleges have had health crises (ones that don’t warrant a full-semester medical leave), their department head or dean has simply said, “Don’t worry about teaching this semester. We’ll figure it out.” I figured the same would happen in my case. To be blunt, the way that my case was handled was a colossal failure of leadership. As my husband and I have shared my story with colleagues at PSU ...